MFS Emerging Markets Debt Fund Class R4
MEDGX
NASDAQ
| Weiss Ratings | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | MFS | |||
| Manager/Tenure (Years) | Ward Brown (18), Neeraj Arora (7) | |||
| Website | http://www.mfs.com | |||
| Fund Information | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | MFS Emerging Markets Debt Fund Class R4 | |||
| Category | Emerging Markets Bond | |||
| Sub-Category | Emerging Markets Fixed Income | |||
| Prospectus Objective | Diversified Emerging Markets | |||
| Inception Date | Dec 01, 2008 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 5.58% | |||
| Dividend | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 9.77% | |||
| Stock | 0.00% | |||
| U.S. Stock | 0.00% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 90.23% | |||
| U.S. Bond | 1.46% | |||
| Non-U.S. Bond | 88.77% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.35% | |||
| 30-Day Total Return | 0.24% | |||
| 60-Day Total Return | -0.47% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 2.44% | |||
| 1-Year Total Return | 7.38% | |||
| 2-Year Total Return | 15.34% | |||
| 3-Year Total Return | 31.85% | |||
| 5-Year Total Return | 12.79% | |||
| Price | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $12.59 | |||
| 1-Month Low NAV | $12.59 | |||
| 1-Month High NAV | $12.68 | |||
| 52-Week Low NAV | $12.38 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $12.94 | |||
| 52-Week High Price (Date) | Feb 18, 2026 | |||
| Beta / Standard Deviation | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.96 | |||
| Standard Deviation | 6.26 | |||
| Balance Sheet | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 7.54B | |||
| Operating Ratios | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.82% | |||
| Turnover Ratio | 69.00% | |||
| Performance | MEDGX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 13.07% | |||
| Last Bear Market Total Return | -11.55% | |||